Efficacy of contact trans-scleral diode laser cyclophotocagulation for neovascular glaucoma
JBMS-Journal of the Bahrain Medical Society. 2004; 16 (3): 123-127
en Inglés
| IMEMR
| ID: emr-66334
ABSTRACT
This prospective study was conducted to evaluate the effectiveness of contract trans-scleral diode laser cyclophotocoagulation [TSCPC] for Neovascular glaucoma.20 eyes of nineteen patients with Neovascular glaucoma on maximum medical treatment were consecutively treated by TSCPC. Success rate was defined as IOP of 5-25 mmHg in eyes of VA> hand movement [HM]; or relief of pain in eyes with VA= HM including blind eyes [NPL] and reduction of eye drops used in all eyes TSCPC treatment was performed with the center of the proble 1.5 mm behind the limbus, 28-30 pulses were applied for 270 degrees around the cornea.Results:
19 patients were followed up for 1 year after initial treatment. The overall success was bout 74% within one year 30 laser procedure was performed; mean 1.55 per patient. As for complications, there was no phthisis bulbi, persistent hypotonia, or sympathetic ophthalmia; however hyphema and moderate inflammatory reaction each occurred in 15%.Trans- scleral diode laser cyclo- photocoagulation is an effective method for the treatment of Neovascular glaucoma
Buscar en Google
Índice:
IMEMR (Mediterraneo Oriental)
Asunto principal:
Esclerótica
/
Estudios Prospectivos
/
Rayos Láser
/
Fotocoagulación
Límite:
Femenino
/
Humanos
/
Masculino
Idioma:
Inglés
Revista:
J. Bahrain Med. Soc.
Año:
2004
Similares
MEDLINE
...
LILACS
LIS